http://rdf.ncbi.nlm.nih.gov/pubchem/reference/32206242

Outgoing Links

Predicate Object
contentType Comparative Study|Evaluation Study|Journal Article|Multicenter Study
endingPage 173
issn 1563-258X
0043-5341
issueIdentifier 5-6
pageRange 169-173
publicationName Wiener medizinische Wochenschrift (1946)
startingPage 169
bibliographicCitation Petru E, Andel J, Angleitner-Boubenizek L, Steger G, Bernhart M, Busch K, Gehmacher O, Hernler T, Kastner U, Lanz-Veit A, Pluschnigg U, Polachova J, Rohde M, Schiller L, Schramböck R, Stangl W, Thödtmann R, Zabernigg A. Early Austrian multicenter experience with palonosetron as antiemetic treatment for patients undergoing highly or moderately emetogenic chemotherapy. Wiener Medizinische Wochenschrift. 2008 Mar;158(5-6):169–73. doi: 10.1007/s10354-008-0515-1.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e4dd98cb78adfc24d0678deaf900ad82
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0dfce695c9750b38e7b5f13b2fa092e1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_72e4bb10b52bb3f31a4ca10576926ca3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_954cca07f61d625dfb334c7870f6b7d5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_31540e7956a965470b28066c68f09420
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_77b89224477fc69dc73c3f714c8e8298
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b04b6f772b2d5fb0cea5c30f222545cd
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0fd64e8e001f1dfb6782833d360ca14f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a97cf247610a096d5bc2685d89214bc6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ef002c56a7cb56edd225204011f8626a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b7ce97c87fa9d3c009a7c1b3c860b962
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3670d2d656c6b83e1027902c02e58db8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0cfb8fb81bcf11659e73791c649c3b74
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1ef9a46e08f71d580c03ac52e1154c11
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b67e61c59978ad8cb71ff56cd181c686
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9a118ea23f4dbae964edab9b12983890
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2275283b5cf9e22fcb710d85a078ecde
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dc969322a30f568e2db7d36e1daefa15
date 200803
identifier https://doi.org/10.1007/s10354-008-0515-1
https://pubmed.ncbi.nlm.nih.gov/18421559
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8081
https://portal.issn.org/resource/ISSN/1563-258X
https://portal.issn.org/resource/ISSN/0043-5341
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
https://scigraph.springernature.com/
title Early Austrian multicenter experience with palonosetron as antiemetic treatment for patients undergoing highly or moderately emetogenic chemotherapy
discusses http://id.nlm.nih.gov/mesh/M0011785
http://id.nlm.nih.gov/mesh/M0019685
http://id.nlm.nih.gov/mesh/M0001391
http://id.nlm.nih.gov/mesh/M0221985
http://id.nlm.nih.gov/mesh/M0544719
http://id.nlm.nih.gov/mesh/M0001483
http://id.nlm.nih.gov/mesh/M0018359
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5702198
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID426756
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6337614
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2907
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3385
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9614

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127952853
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129095671
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136224371

Total number of triples: 56.